< Back to previous page
Researcher
Isabelle Huys
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Faculty of Law and Criminology (Faculty)
Member
From1 Oct 2014 → 30 Sep 2015 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Toxicology and Pharmacology (Division)
Member
From1 Oct 1999 → 9 Mar 2004
Projects
21 - 30 of 66
- Gene Therapy for rare inherited Arrhythmogenic Cardiomyopathy: towards a patient-centered implementation pathwayFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stakeholder perspectives on gene therapyFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom11 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom1 Sep 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Patient Experience Data for Innovative TherapiesFrom31 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- NEED for rare conditions. Identification of unmet patient and societal needs in healthcare - Applicability of a framework to rare diseasesFrom2 May 2023 → 26 Mar 2024Funding: Belgian Health Care Knowledge Centre (KCE)
- Gene Therapy for treatment of rare inherited Arrhythmogenic CardiomyopathyFrom1 May 2023 → TodayFunding: HORIZON.2.1 - Health
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- European Cancer Imaging InitiativeFrom1 Jan 2023 → TodayFunding: Digital Europe Programme (DIGITAL)
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 233
- Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis(2025)Published in: United European gastroenterology journalISSN: 2050-6406Issue: 4Volume: 13Pages: 542 - 551
- Drawing on collective action theory to foster sustainable biosimilar markets - insights from co-creation workshops with UK and Belgian stakeholders(2025)Published in: Expert Opinion on Biological TherapyISSN: 1471-2598Issue: 4Volume: 25Pages: 437 - 446
- Non-clinical platform to predict exposure to maternal medicines via breastfeeding(2025)
- Information Service "My Cancer Navigator" to Support Shared Decision-Making: An Online Survey Among Patients with Cancer and Their Caregivers(2025)Published in: Journal of Health CommunicationISSN: 1081-0730Issue: 1-3Volume: 30Pages: 82 - 92
- Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews(2025)Published in: Frontiers in PharmacologyISSN: 1663-9812Volume: 15
- Do European regulatory measures accelerate national market access in Belgium? A retrospective analysis of medicines centrally authorised between 2015 and 2020(2025)Published in: Bmj OpenISSN: 2044-6055Issue: 1Volume: 15
- Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation(2025)Published in: Frontiers in MedicineISSN: 2296-858XVolume: 11
- Development and Characterization of a Human Mammary Epithelial Cell Culture Model for the Blood-Milk Barrier-A Contribution from the ConcePTION Project(2024)Published in: International Journal of Molecular SciencesISSN: 1661-6596Issue: 21Volume: 25
- Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review(2024)Published in: Pharmaceutical MedicineISSN: 1178-2595Issue: 6Volume: 38Pages: 429 - 455
- Heart failure patients' perspectives on treatment outcomes and unmet medical needs: A qualitative preference study(2024)Published in: ESC Heart FailureISSN: 2055-5822Issue: 5Volume: 11Pages: 2481 - +